No Photo Available

Last Update


This profile was last updated on .

Is this you? Claim your profile.

Wrong Brendan Shaw?

Dr. Brendan Shaw

Managing Director

AstraZeneca PLC

HQ Phone: +44 20 7604 8000

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

AstraZeneca PLC

2 Kingdom Street

London, Greater London W2 6BD

United Kingdom

Company Description

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Oncology, Cardiovascular & Met ... more

Find other employees at this company (35,419)

Background Information

Employment History



Chief Executive Officer, Medicines Australia

Research Australia Limited


Chief Executive Officer

Medicines Australia

Assistant Director General

International Federation of Pharmaceutical Manufacturers and Associations


Board Member

Board Member
Pharmaceuticals Industry Council





Monash University

honors degree


University of Queensland

Web References (168 Total References)

New MA Chairman starts today | Medicines Australia [cached]

"We welcome Martin to the position of Chairman of Medicines Australia," said Medicines Australia Chief Executive, Dr Brendan Shaw.

"I also want to thank Mr Mark Fladrich, Managing Director of AstraZeneca and MA Board member, for stepping in as Chairman before Martin's appointment," Dr Shaw said.

GMiA code to level playing field: MA | Pharmacy News [cached]

MA chief executive Dr Brendan Shaw welcomed the authorisation of the code, describing it as a step in the right direction.

"We look forward to a more even operating environment [and] if this achieves the outcome of a more level playing field then it's a positive move," he said.

Inconsistent regulation could force R&D overseas | Pharmacy News [cached]

Medicines Australia chief executive Dr Brendan Shaw warned inconsistent processes for ethical approval for trials in different states has been acting "like a handbrake" and could force research and development overseas.

While the Federal Government has established the Clinical Trials Action Group to encourage clinical trials in Australia, Dr Shaw said it was important to minimise the hurdles to setting up trials.
"Compared to a number of other countries, in Australia there is a lack of coordination between the states for ethical approval of clinical trials, the time to get clinical trials established is too long, and the methods for recruiting patients to clinical trials are outdated," Dr Shaw said.

Election stalls PBS reform | Pharmacy News [cached]

However Medicines Australia chief executive Brendan Shaw told Pharmacy eNews there was an urgent need to get the legislation through parliament as soon as possible.

"It's very important that the enabling legislation is passed as early as possible, so that savings can start to flow to Government and to patients.
"Medicines Australia stands by its submission [to Senate Community Affairs Legislation committee inquiry into the MoU], which urges the passage of the legislation before 1 October," he said.
Mr Sclavos was critical of Mr Shaw's comments saying, "Brendan Shaw and Medicines Australia don't have to deal with the patients of Australia, we do.
"Brendan Shaw doesn't represent the members who are going to be changing their trading terms, that's the Generic Medicines Industry Association.
"If it's 1 October there's no time for pharmacists to adjust to that new trading environment and new deals," he said.

Our Experts – IFPMA [cached]

Brendan Shaw

Assistant Director General
Brendan Shaw is Assistant Director General at IFPMA and was appointed in 2014. Brendan assists the Director General in leading on a range of policy and representational functions particularly in innovation policy, intellectual property, trade, health technology assessment, ethics, compliance and vaccines. Brendan holds an honors degree in economics from the University of Queensland and a PhD in management, business and economics from Monash University. Prior to joining IFPMA, Brendan was Chief Executive of the Australian pharmaceutical industry association, Medicines Australia, and before that was the senior executive at MA in charge of health policy and research. Brendan has also worked as an economist and policy advisor in government and politics, in academia and as a consultant.
Brendan Shaw
Assistant Director General

Similar Profiles

Other People with this Name

Other people with the name Shaw

Gary Shaw
SNC-Lavalin Inc.

Clair Shaw
Adams Outdoor Advertising Ltd

Tristan Shaw
The Training Room Online

Shelley Shaw
Rotherham Metropolitan Borough Council

Kimberly Shaw
Sunquest Information Systems , Inc.

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory